These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3306001)

  • 21. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in patients with leukemia].
    Löwenberg B; Sizoo W; Wagemaker G; Sintnicolaas K; Hendriks WD; Hagenbeek A
    Ned Tijdschr Geneeskd; 1986 May; 130(19):872-6. PubMed ID: 3520349
    [No Abstract]   [Full Text] [Related]  

  • 22. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
    Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical application of bone marrow transplantation].
    Lu DP
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):75-7. PubMed ID: 8404327
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe cutaneous ulceration following treatment with thalidomide for GVHD.
    Schlossberg H; Klumpp T; Sabol P; Herman J; Mangan K
    Bone Marrow Transplant; 2001 Jan; 27(2):229-30. PubMed ID: 11281398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation].
    Iriondo A; Richard C; Hermosa V; Conde E; Garijo J; Cuadrado MA; Bello C; Muruzábal MJ; Pérez-Encinas M; Zubizarreta A
    Med Clin (Barc); 1988 Oct; 91(13):488-92. PubMed ID: 3067007
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation by removal of T-cells].
    de Gast GC; Verdonck LF; van Kempen-Harteveld ML; Gerritsen H; Dekker AW
    Ned Tijdschr Geneeskd; 1986 May; 130(19):868-71. PubMed ID: 3520348
    [No Abstract]   [Full Text] [Related]  

  • 27. Marrow vs peripheral blood: impact on transplant outcome.
    Forman SJ
    Leukemia; 2001 Apr; 15(4):686-7. PubMed ID: 11368382
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia.
    Santos GW
    Cancer Detect Prev; 1988; 12(1-6):589-96. PubMed ID: 3052840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry.
    Bortin MM; Horowitz MM; Rowlings PA; Rimm AA; Sobocinski KA; Zhang MJ; Gale RP
    Bone Marrow Transplant; 1993 Aug; 12(2):97-104. PubMed ID: 8401371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report].
    Chen YC; Wang CH; Lin DT; Lui PT; Cheng AL; Liu TW; Tsay W; Tien HF; Liu MC; Chuu WM
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):490-6. PubMed ID: 3305776
    [No Abstract]   [Full Text] [Related]  

  • 32. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
    Hirabayashi N; Yano K; Yokomaku S; Morishima Y; Iwamura H; Naito K; Kodera Y; Matsuyama K; Nakaide Y; Yamada H
    Rinsho Ketsueki; 1988 Mar; 29(3):313-9. PubMed ID: 3294471
    [No Abstract]   [Full Text] [Related]  

  • 33. New donor leukocyte approaches may improve outcomes in relapsed CML post-transplant.
    Oncology (Williston Park); 1996 Sep; 10(9):1380. PubMed ID: 8882927
    [No Abstract]   [Full Text] [Related]  

  • 34. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
    Champlin R
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation in malignant diseases and aplastic anemia.
    Zander AR; Dicke KA
    Tex Med; 1984 Jul; 80(7):40-2. PubMed ID: 6379970
    [No Abstract]   [Full Text] [Related]  

  • 36. Present status of bone marrow transplantation in Japan.
    Masaoka T
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1491-8. PubMed ID: 3551434
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of cyclosporin A in 5 leukemia patients receiving allogeneic bone marrow transplantation].
    Akao Y; Sao H; Tahara T; Yoshikawa H; Yoshikawa S; Morishima Y; Hiraiwa A; Naoe T
    Rinsho Ketsueki; 1984 Sep; 25(9):1417-26. PubMed ID: 6394783
    [No Abstract]   [Full Text] [Related]  

  • 38. Allogeneic bone marrow transplantation for acute leukemia in children. A short review.
    Masotti A; Baccarani M
    Haematologica; 1985; 70(6):536-44. PubMed ID: 3938434
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cyclosporine in allogeneic bone marrow transplantation in children].
    Kojima S; Fukuda M; Horibe K; Matsuyama K
    Rinsho Ketsueki; 1987 Sep; 28(9):1576-82. PubMed ID: 3325658
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bone marrow transplantation in England].
    Zhonghua Nei Ke Za Zhi; 1984 Nov; 23(11):712-3. PubMed ID: 6398213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.